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Nestle et al.7 suggested that DF is an abortive immune process
mediated by dermal dendritic cells, thus, any drug down-regulat-
ing T cells, such as imatinib in our cases, might favour the
appearance of multiple DF through an exaggerated response to
an unknown pathogen.2 We found only one case report of MEDF
in a patient with CML.8 That case occurred after an aplastic epi-
sode and the authors considered the MEDF secondary to immu-
nosuppression. Our second case could be included in this second
group, as he presented the lesions during a worsening of his dis-
ease due to a failure of imatinib treatment, but our first patient
would fit better taking into account the Nestle′s hypotheses.
Our patients did not present any other sign of immunosup-
pression or other systemic diseases. This supports the pathogenic
role of imatinib in the development of the MEDF. So, dermatol-
ogist should be aware of the appearance of MEDF in patients
with CML as it should be an alarm bell to start a work up to rule
out immunosuppression or treatment failure.
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Adult-onset eccrine
angiomatous hamartoma: report
of a rare entity with unusual
histological features
Editor
Eccrine angiomatous hamartoma (EAH) is a rare hyperplasia of
eccrine glands and dermal capillaries. It typically presents during
childhood as a slowly growing, bluish-purple nodule or plaque
on the distal extremities, and may be associated with pain,
hyperhidrosis, and/or hypertrichosis.1 We report a rare case of
adult-onset EAH notable for its size and previously unreported
histological features that could cause diagnostic confusion with
inflammatory panniculitis.
Two years prior to presentation, a 44-year-old female devel-
oped a 3–4 cm, bruise-like lesion on the left thigh. She reported
occasional pruritus, burning and ‘tightness’ in the lesion, but
denied excessive sweating or hair growth. A punch biopsy per-
formed by an outside practitioner was suggestive of morphea
profunda. Despite treatment with topical steroids and calcipotri-
ene, the lesion continued to grow, and initiation of methotrexate
was being considered.
The patient presented to our dermatology clinic for a
second opinion. Examination revealed a smooth 15 cm
9 8 cm, irregularly shaped, mottled, red-brown plaque with-
out hypertrichosis or hyperhidrosis (Fig. 1). Within the
lesion, several soft, non-tender subcutaneous nodules were
palpable.
To aid in diagnosis, we performed two 6-mm punch biopsies
(Fig. 1). The first from a flesh-coloured nodule was non-diag-
nostic. The second biopsy from a red-brown nodule demon-
strated hyperplastic dermal eccrine coils, prominent perieccrine
mucin, numerous intimately associated capillaries, and a moder-
ately dense, superficial and deep perivascular dermal lympho-
cytic infiltrate with occasional eosinophils (Fig. 2). Dermal
collagen appeared normal. In the subcutis were prominent, wid-
ened, fibrotic septae containing multiple, small periseptal lym-
phocytic aggregates without follicle formation. Spirochete
immunostain was negative.
The histological differential diagnosis included EAH with
unusual histological features vs. a primary inflammatory panni-
culitis. Despite finding periseptal lymphoid aggregates, the pres-
ence of dermal eosinophils and the lack of a lobular lymphocytic
panniculitis or hyaline sclerosis rendered lupus panniculitis unli-
kely. In addition, anti-nuclear antibody testing was negative.
Although septal thickening was present, the degree of dermal
inflammation and the clinical presentation of a persistent plaque
on the thigh were not consistent with erythema nodosum.
Lastly, the absence of hyalinized collagen excluded inflammatory
morphea.
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Altogether, the clinical and histological features were most
consistent with adult-onset EAH. The presence of striking der-
mal eccrine and vascular hyperplasia was pathognomonic. As
the prominent dermal inflammation and subcutaneous septal
fibrosis were not consistent with a specific type of inflammatory
panniculitis, these changes were interpreted as incidental and
secondary. The patient deferred excision due to lack of symp-
toms, and is currently doing well with observation.
Eccrine angiomatous hamartoma is a rare hamartoma that is
typically solitary (86.5%) and located on the extremities
(81.1%).1 Symptoms may include pain (42.4%) and hyperhidro-
sis (34.3%).1 In a review of 37 cases, 45.7% of lesions were con-
genital, with age of presentation ranging from 2 months to
73 years (median age 10 years).1 Only 14 cases of adult-onset
EAH have been described.2,3 The reported sizes of EAH range
from 3 mm to 11 cm.4 Thus, our patient’s lesion is the largest
reported to date.
Both proliferation of eccrine glands and closely associated
capillary angiomatous foci must be present to distinguish EAH
from eccrine nevus and sudoriparous angioma, which lack capil-
lary proliferation and eccrine hyperplasia, respectively.1 Malig-
nant transformation has not been reported.3,5
The treatment of choice for EAH is surgical excision and is
required if there is pain, severe hyperhidrosis or unremitting
growth.1 Observation is reasonable for asymptomatic lesions.1,3
Awareness of the clinical and histological features of EAH is
key to diagnosing this rare hamartoma, particularly in adults.
Distinguishing EAH from inflammatory panniculitis will avoid
aggressive or ineffective treatments. Our case demonstrates hall-
mark histological features of increased eccrine glands in intimate
association with increased vessels. Inflammation and septal
fibrosis are unique findings that have not been reported.
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Figure 1 Clinical presentation of eccrine angiomatous hamartom-
a (EAH). A 44-year-old female presented with a slowly growing,
smooth, red-brown, mottled plaque on left medial thigh with ﬂesh-
coloured (biopsy site 1) and erythematous nodules (biopsy site 2).
(a) (b)
Figure 2 Eccrine angiomatous hamartoma (EAH) with unusual histological features. (a) Low-powered view showing hyperplastic eccrine
coils in the mid-to-deep dermis with unusual features, including a dense perivascular inﬂammatory inﬁltrate and widening of pannicular
septae (haematoxylin–eosin, original magniﬁcation 9 20). (b) High-powered view of hyperplastic eccrine glands with perieccrine mucin
and intimately associated increased small blood vessels (haematoxylin–eosin, original magniﬁcation 9 100).
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